chr7-127610546-A-AGTGT
Position:
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 0P and 4B. BS2
The NM_001366110.1(PAX4):c.*517_*518insACAC variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.0068 ( 3 hom., cov: 0)
Exomes 𝑓: 0.0056 ( 1 hom. )
Consequence
PAX4
NM_001366110.1 3_prime_UTR
NM_001366110.1 3_prime_UTR
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.286
Genes affected
PAX4 (HGNC:8618): (paired box 4) This gene is a member of the paired box (PAX) family of transcription factors. Members of this gene family typically contain a paired box domain, an octapeptide, and a paired-type homeodomain. These genes play critical roles during fetal development and cancer growth. The paired box 4 gene is involved in pancreatic islet development and mouse studies have demonstrated a role for this gene in differentiation of insulin-producing beta cells. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -4 ACMG points.
BS2
High AC in GnomAd4 at 972 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
PAX4 | NM_001366110.1 | c.*517_*518insACAC | 3_prime_UTR_variant | 12/12 | ENST00000639438.3 | ||
PAX4 | NM_001366111.1 | c.*305_*306insACAC | 3_prime_UTR_variant | 10/10 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
PAX4 | ENST00000639438.3 | c.*517_*518insACAC | 3_prime_UTR_variant | 12/12 | 5 | NM_001366110.1 | A2 | ||
PAX4 | ENST00000341640.6 | c.*517_*518insACAC | 3_prime_UTR_variant | 9/9 | 1 |
Frequencies
GnomAD3 genomes AF: 0.00679 AC: 966AN: 142216Hom.: 2 Cov.: 0
GnomAD3 genomes
AF:
AC:
966
AN:
142216
Hom.:
Cov.:
0
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.00561 AC: 348AN: 62014Hom.: 1 Cov.: 0 AF XY: 0.00554 AC XY: 179AN XY: 32330
GnomAD4 exome
AF:
AC:
348
AN:
62014
Hom.:
Cov.:
0
AF XY:
AC XY:
179
AN XY:
32330
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00683 AC: 972AN: 142316Hom.: 3 Cov.: 0 AF XY: 0.00699 AC XY: 485AN XY: 69400
GnomAD4 genome
AF:
AC:
972
AN:
142316
Hom.:
Cov.:
0
AF XY:
AC XY:
485
AN XY:
69400
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Maturity onset diabetes mellitus in young Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at